Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Information
Camrelizumab is a potent anti-PD-1 /PD-L1 active molecule that can be used in cancer research, including non-small cell lung cancer, esophageal squamous cell carcinoma, Hodgkin lymphoma, and advanced liver cancer.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg
Camrelizumab (anti-PD-1) (C412007) - Flow Cytometry
Flow Cytometry analysis of 5μg/mL PHA stimulated 3 days human peripheral blood lymphocytes labelling PD-1 (red) with Camrelizumab (anti-PD-1) (C412007) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, human IgG (Ab170213) conjugated with biotin. Black - Unlabelled control, cells without incubation with primary antibody.
Camrelizumab (anti-PD-1) (C412007) - Flow Cytometry
Flow Cytometry analysis of MOLT-4 cells labelling PD-1 (red) with Camrelizumab (anti-PD-1) (C412007). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Camrelizumab (anti-PD-1) (C412007) - SEC
The purity of Camrelizumab (anti-PD-1) (C412007) is more than 95% verified by HPLC.
Camrelizumab (anti-PD-1) (C412007) - ELISA
Immobilized TARGET at 2 μg/mL can bind Camrelizumab (anti-PD-1) (C412007) with the EC₅₀ of 8.25 ng/mL.
Camrelizumab (anti-PD-1) (C412007) - ELISA
Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Camrelizumab (anti-PD-1) (C412007) with the EC50 of 10.39 ng/mL.
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0607389 | Certificate of Analysis | Jun 26, 2024 | C412007 |
| ZJ23F1202075 | Certificate of Analysis | Dec 20, 2023 | C412007 |
| ZJ23F1202074 | Certificate of Analysis | Dec 20, 2023 | C412007 |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Animal Free grade guide → View Carrier Free grade guide → View Recombinant grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide → View Azide Free grade guide →
